Atópiás dermatitisz (ekcéma): vizsgálatok itt: Mexikó
4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Where
- Chihuahua City, Mexico City, Monterrey, Veracruz
- Életkor
- 2 év to 11 év
- People
- 450 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807281 · EU 2023-509124-18-00 - 3. fázisCsak meghívásosA Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Chihuahua City, Cuernavaca, Mexico City, Monterrey, Veracruz, Zapopan
- Életkor
- 6 hónap to 18 év
- People
- 338 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00 - 3. fázisTaking peopleA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Where
- Chihuahua City, Mexico City, Monterrey, Veracruz
- Életkor
- 6 év to 11 év
- People
- 150 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807268 · EU 2023-509121-51-00 - No phaseTaking peopleEffect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
- Where
- Aguascalientes
- Életkor
- 2 év to 12 év
- People
- 20
- Run by
- Universidad Autónoma de Aguascalientes
See details and how to joinNCT07259343